凯发k8国际/en
凯发k8国际 / en
fda commissioner scott gottlieb, m.d., on new steps fda is taking to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs
visited to huali group and colluded with the "big health" industrial ecosystem